Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

Paricalcitol Reduced Residual Renal Risk in Diabetic Nephropathy Patients - Internal Medicine News Digital Network PDF Print
Internal Medicine News Digital NetworkSelective vitamin D receptor activation with paricalcitol lowers residual albuminuria and could provide renal protection in patients with diabetic ...Vitamin-D analog could lower renal risk in diabetic nephropathy TheHeart.OrgParicalcitol Reduces Residual Albuminuria in Patients With Type 2 Diabetic

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.